Chat with us, powered by LiveChat

Loading...
Coagulation Testing Market, by Product Type

RA00086

Coagulation Testing Market, by Product Type (Instruments, Consumables), by Application (Prothrombin Time, Activated Partial Thromboplastin Time, Thrombin Time, And Activated Clotting Time), by End-Use (Hospitals, Clinical Laboratories, Point-of-Care Testing, Others), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026

RA00086

Pages: 105

Feb 2020

COVID-19

pandemic has shown to have an enormous impact on most
industries.

Click Here to access our comprehensive analysis of the

Impact of covid-19 on Coagulation Testing Market

Global Coagulation Testing Market Insights 2026:

The global coagulation testing market forecast will be $3,566.0 million by 2026, increasing from $2,241.4 million in 2018 at a healthy CAGR of 5.9%. Europe coagulation testing market is expected to grow at a healthy CAGR of 6.2% by registering a revenue of $1,094.8 million by 2026. Asia-Pacific coagulation testing market shall generate a revenue of $848.7 million by 2026. Growing chronic blood disease cases will significantly boost the coagulation testing market in the projected period.

Blood Coagulation or clotting is a change in physical properties of the blood due to the conversion of a fibrinogen, soluble plasma protein, into a fibrin, solid gel. Coagulation tests are mainly performed by a coagulometer which analyzes the ability of the blood to clot and the blood clotting time. 

Massively growing cases of chronic blood diseases are expected to drive the Global Coagulation Testing Market

The rising demand for special hematology and coagulation laboratory is anticipated to drive the growth of coagulation testing market. Advanced technologies such as fluorescent microscopy, microfluidics, electrochemical sensing, and photoacoustic detection, are used to develop cost-effective and highly robust, point of care (POC) devices. POC devices mainly measure optical, mechanical, and electrochemical parameters of clotting blood. These technological inventions are anticipated to boost the growth of coagulation testing market. Furthermore, extensively rising cardiovascular problem and chronic blood diseases are anticipated to boost the growth of global market. For example, as per study of World Health organization (WHO), annually, around 31% of all deaths of patients occur due to cardiovascular diseases (CVDs).

Higher cost of coagulation devices and lack of professionals is anticipated to restrain the growth of global Coagulation Testing Industry

Lack of skilled labors and higher cost of devices may decline the global market growth. 

Recent inventions such as Smartphone-enabled Coagulation Tests are projected to create enormous opportunities for the coagulation testing industry

The smartphone-based blood coagulation test is anticipated to drive the growth of the market. In this self-testing technology, this device monitors flow of blood in patients undergoing anticoagulant therapy. The gadget provides facility to patients to perform this test at home. Two main coagulation indexes such as prothrombin time (PT) and activated partial thromboplastin time (APTT) can be measured on this platform. These platforms are highly reliable and effective. These coagulation testing market trends can create enormous opportunities for the coagulation testing market growth. 

Coagulation Testing Market, by Type:

Instruments segment will be most lucrative till 2026
 Coagulation Testing Market, by Type

Source: Research Dive Analysis

Consumable segment has the highest share in the market, and it has registered a revenue of $1,187.9 million in 2018 and is anticipated to surpass $1,847.2 million by 2026.Instruments segment is the fastest growing in the market, and it will generate a revenue of $1,718.8 Million in 2026. Tremendous growth in diagnostic centers across the globe, enhanced diagnostic tools, improved treatment monitoring, and heavy investments in the R&D are anticipated to drive the growth of global market.

Coagulation Testing Market, by Application:

Thrombin Time segment will register revenue of $392.3 million by 2026
 Coagulation Testing Market, by Application

Source: Research Dive Analysis

Coagulation testing market size of prothrombin time will generate a revenue of $2,475.7 million throughout the forecast period. 

Clotting time tests like prothrombin time are frequently performed in an outpatient or hospital setting for the evaluation of the hemostatic system. Newly invented prothrombin time testing devices are integrated with sensor technology which are faster and user friendly. Furthermore, the rising prevalence of cardiovascular problems, blood disorders and increased demand for point of care testing is projected to fuel the growth of the global market, during the forecast period. Thrombin time global market will register a revenue of $392.3 million during the projected period. 

Coagulation Testing Market, by End-Use:

Point-of-Care Testing segment will register revenue of $495.7 million by 2026

Coagulation Testing Market, by End-Use

Source: Research Dive Analysis

Point-of-Care testing segment is a rapidly progressing segment in the global market, and it has registered a revenue of $291.4 million in 2018 and is expected to generate a revenue of $495.7 million by 2026.
The increasing economic pressures on hospitals and rising competition among therapist and suppliers, is expected to drive the growth of global market. Moreover, clinicians are reviewing developing technologies, and also ensuring that patients benefit from new advancements. Perioperative coagulation point-of-care testing (POCT) offers complex interactions within the clotting system, reduces turnaround test times, and also lessens inappropriate transfusion.

Coagulation Testing Market system, by Region:

Europe Coagulation Testing Market Overview 2026: 

Europe coagulation testing market share is anticipated to rise at a CAGR of 6.2% by generating a revenue of $1,094.8 million by 2026. This is majorly because of the latest advancements and strategies and the most current updates in the field of. Annually, cardiovascular disease (CVD) accounts for 3.9 million deaths in Europe i.e. CVD causes 45% of all deaths in Europe. In addition, death rates from both ischaemic heart disease and stroke are generally higher in Eastern and central Europe; these deaths are anticipated to drive the demand for coagulation test services and eventually boost the growth of coagulation test in Europe market.

Asia-Pacific region will have lucrative opportunities for the market investors 

Asia-Pacific coagulation testing market size will generate a revenue of $848.7 million by 2026. Extensively rising demand for foreign investments and poor lifestyle are major factors for the growth of coagulation testing market. Moreover, road accidents frequently of a collision type can cause harmful injuries such as blood clots and head trauma. These are the leading cause of death cases among age of 15-30, occurring in Asian countries such as China and India; this is linked to the demand in the growth for the coagulation testing market. 

Followed by APAC and Europe region, Sample report reveal North American market growth, request to download sample report at
https://www.researchdive.com/download-sample/86

Key Participants in Global Coagulation Testing Market:

Merger & acquisition and advanced product development are the frequent strategies followed by the market players
 Key participants in global Coagulation Testing Market

Source: Research Dive Analysis

Some of the significant coagulation testing market players include: Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION., Abbott., Sysmex Corporation, BD., Danaher.

Market Players prefer inorganic growth strategies to expand into local markets. 

Coagulation testing market players are emphasizing more on merger & acquisition and advanced product development. These are the frequent strategies followed by the established organizations. To emphasize more on the competitor analysis of market players, the porter’s five force model is explained in the report.

Aspect

Particulars

  Historical Market Estimations

  2018-2019

  Base Year for Market Estimation

  2018

  Forecast timeline for Market Projection

  2019-2026

  Geographical Scope

  North America, Europe, Asia-Pacific, LAMEA

  Segmentation by Product Type

  • Instruments
  • Consumables

  Segmentation by Application

  • Prothrombin Time
  • Activated Partial Thromboplastin Time
  • Thrombin Time
  • Activated Clotting Time

  Segmentation by End-Use

  • Hospitals
  • Clinical Laboratories
  • Point-of-Care Testing
  • Others

  Key Countries Covered

U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia

  Key Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Helena Laboratories Corporation.
  • Micropoint Biosciences
  • Medtronic
  • F. Hoffmann-La Roche Ltd
  • NIHON KOHDEN CORPORATION.
  • Abbott.
  • Sysmex Corporation
  • BD.
  • Danaher.

Source: Research Dive Analysis


FREQUENTLY ASKED QUESTIONS?
 

A. The global coagulation testing market system size was over $3,566.0 million in 2018, and is projected to reach $2,2241.4 million by 2026.

A. Abbott., BD., Danaher. are some of the key players in the global coagulation testing market.

A. Asia-Pacific region possess great investment opportunities for the investors to witness the most promising growth in the future.

A. Asia-Pacific coagulation testing market is anticipated to grow at 6.4% CAGR during the forecast period.

A. Technological advancements, product development, along with joint ventures are the key strategies opted by the operating companies in this market.

A. Thermo Fisher Scientific Inc. and Medtronic companies are investing more on R&D activities for developing new products and technologies.

1. Research Methodology

1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters

1.4.1. Assumptions
1.4.2. Forecast parameters

1.5. Data sources

1.5.1. Primary
1.5.2. Secondary

2. Executive Summary

2.1. 360° summary
2.2. Product Type Trends
2.3. Application Trends
2.4. End Use Trends

3. Market Overview

3.1. Market segmentation & definitions
3.2. Key takeaways

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market

3.4. Market dynamics

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Strategic overview

4. Coagulation Test Market, by Product Type

4.1. Printers

4.1.1. Market size and forecast, by region, 2018-2026
4.1.2. Comparative market share analysis, 2018 & 2026

4.2. Materials

4.2.1. Market size and forecast, by region, 2018-2026
4.2.2. Comparative market share analysis, 2018 & 2026

5. Coagulation Test Market, by Application

5.1. Prothrombin Time 

5.1.1. Market size and forecast, by region, 2018-2026
5.1.2. Comparative market share analysis, 2018 & 2026

5.2. Activated Partial Thromboplastin Time

5.2.1. Market size and forecast, by region, 2018-2026
5.2.2. Comparative market share analysis, 2018 & 2026

5.3. Thrombin Time

5.3.1. Market size and forecast, by region, 2018-2026
5.3.2. Comparative market share analysis, 2018 & 2026

5.4. Activated Clotting Time

5.4.1. Market size and forecast, by region, 2018-2026
5.4.2. Comparative market share analysis, 2018 & 2026

6. Coagulation Test Market, by End Use

6.1. Hospitals

6.1.1. Market size and forecast, by region, 2018-2026
6.1.2. Comparative market share analysis, 2018 & 2026

6.2. Clinical Laboratories

6.2.1. Market size and forecast, by region, 2018-2026
6.2.2. Comparative market share analysis, 2018 & 2026

6.3. Point-of-Care Testing

6.3.1. Market size and forecast, by region, 2018-2026
6.3.2. Comparative market share analysis, 2018 & 2026

6.4. Others

6.4.1. Market size and forecast, by region, 2018-2026
6.4.2. Comparative market share analysis, 2018 & 2026

7. Coagulation Test Market, by Region

7.1. North America

7.1.1. Market size and forecast, by product type, 2018-2026
7.1.2. Market size and forecast, by application, 2018-2026
7.1.3. Market size and forecast, by end use, 2018-2026
7.1.4. Market size and forecast, by country, 2018-2026
7.1.5. Comparative market share analysis, 2018 & 2026

7.1.6. U.S.

7.1.6.1. Market size and forecast, by product type, 2018-2026
7.1.6.2. Market size and forecast, by application, 2018-2026
7.1.6.3. Market size and forecast, by end use, 2018-2026
7.1.6.4. Comparative market share analysis, 2018 & 2026

7.1.7. Canada

7.1.7.1. Market size and forecast, by product type, 2018-2026
7.1.7.2. Market size and forecast, by application, 2018-2026
7.1.7.3. Market size and forecast, by end use, 2018-2026
7.1.7.4. Comparative market share analysis, 2018 & 2026

7.2. Europe

7.2.1. Market size and forecast, by product type, 2018-2026
7.2.2. Market size and forecast, by application, 2018-2026
7.2.3. Market size and forecast, by end use, 2018-2026
7.2.4. Market size and forecast, by country, 2018-2026
7.2.5. Comparative market share analysis, 2018 & 2026
7.2.6. Germany 

7.2.6.1. Market size and forecast, by product type, 2018-2026
7.2.6.2. Market size and forecast, by application, 2018-2026
7.2.6.3. Market size and forecast, by end use, 2018-2026
7.2.6.4. Comparative market share analysis, 2018 & 2026

7.2.7. UK

7.2.7.1. Market size and forecast, by product type, 2018-2026
7.2.7.2. Market size and forecast, by application, 2018-2026
7.2.7.3. Market size and forecast, by end use, 2018-2026
7.2.7.4. Comparative market share analysis, 2018 & 2026

7.2.8. France

7.2.8.1. Market size and forecast, by product type, 2018-2026
7.2.8.2. Market size and forecast, by application, 2018-2026
7.2.8.3. Market size and forecast, by end use, 2018-2026
7.2.8.4. Comparative market share analysis, 2018 & 2026

7.2.9. Spain

7.2.9.1. Market size and forecast, by product type, 2018-2026
7.2.9.2. Market size and forecast, by application, 2018-2026
7.2.9.3. Market size and forecast, by end use, 2018-2026
7.2.9.4. Comparative market share analysis, 2018 & 2026

7.2.10. Italy 

7.2.10.1. Market size and forecast, by product type, 2018-2026
7.2.10.2. Market size and forecast, by application, 2018-2026
7.2.10.3. Market size and forecast, by end use, 2018-2026
7.2.10.4. Comparative market share analysis, 2018 & 2026

7.2.11. Rest of Europe

7.2.11.1. Market size and forecast, by product type, 2018-2026
7.2.11.2. Market size and forecast, by application, 2018-2026
7.2.11.3. Market size and forecast, by end use, 2018-2026
7.2.11.4. Comparative market share analysis, 2018 & 2026

7.3. Asia Pacific

7.3.1. Market size and forecast, by product type, 2018-2026
7.3.2. Market size and forecast, by application, 2018-2026
7.3.3. Market size and forecast, by end use, 2018-2026
7.3.4. Market size and forecast, by country, 2018-2026
7.3.5. Comparative market share analysis, 2018 & 2026
7.3.6. China

7.3.6.1. Market size and forecast, by product type, 2018-2026
7.3.6.2. Market size and forecast, by application, 2018-2026
7.3.6.3. Market size and forecast, by end use, 2018-2026
7.3.6.4. Comparative market share analysis, 2018 & 2026

7.3.7. India 

7.3.7.1. Market size and forecast, by product type, 2018-2026
7.3.7.2. Market size and forecast, by application, 2018-2026
7.3.7.3. Market size and forecast, by end use, 2018-2026
7.3.7.4. Comparative market share analysis, 2018 & 2026

7.3.8. Australia 

7.3.8.1. Market size and forecast, by product type, 2018-2026
7.3.8.2. Market size and forecast, by application, 2018-2026
7.3.8.3. Market size and forecast, by end use, 2018-2026
7.3.8.4. Comparative market share analysis, 2018 & 2026

7.3.9. Rest of Asia Pacific

7.3.9.1. Market size and forecast, by product type, 2018-2026
7.3.9.2. Market size and forecast, by application, 2018-2026
7.3.9.3. Market size and forecast, by end use, 2018-2026
7.3.9.4. Comparative market share analysis, 2018 & 2026

7.4. LAMEA

7.4.1. Market size and forecast, by product type, 2018-2026
7.4.2. Market size and forecast, by application, 2018-2026
7.4.3. Market size and forecast, by end use, 2018-2026
7.4.4. Market size and forecast, by country, 2018-2026
7.4.5. Comparative market share analysis, 2018 & 2026
7.4.6. Latin America  

7.4.6.1. Market size and forecast, by product type, 2018-2026
7.4.6.2. Market size and forecast, by application, 2018-2026
7.4.6.3. Market size and forecast, by end use, 2018-2026
7.4.6.4. Comparative market share analysis, 2018 & 2026

7.4.7. Middle East 

7.4.7.1. Market size and forecast, by product type, 2018-2026
7.4.7.2. Market size and forecast, by application, 2018-2026
7.4.7.3. Market size and forecast, by end use, 2018-2026
7.4.7.4. Comparative market share analysis, 2018 & 2026

7.4.8. Africa

7.4.8.1. Market size and forecast, by product type, 2018-2026
7.4.8.2. Market size and forecast, by application, 2018-2026
7.4.8.3. Market size and forecast, by end use, 2018-2026
7.4.8.4. Comparative market share analysis, 2018 & 2026

8. Company Profiles

8.1. Thermo Fisher Scientific Inc.

8.1.1. Business overview
8.1.2. Financial performance
8.1.3. Product portfolio
8.1.4. Recent strategic moves & developments
8.1.5. SWOT analysis

8.2. Helena Laboratories Corporation.

8.2.1. Business overview
8.2.2. Financial performance
8.2.3. Product portfolio
8.2.4. Recent strategic moves & developments
8.2.5. SWOT analysis

8.3. Micropoint Biosciences

8.3.1. Business overview
8.3.2. Financial performance
8.3.3. Product portfolio
8.3.4. Recent strategic moves & developments
8.3.5. SWOT analysis

8.4. Medtronic

8.4.1. Business overview
8.4.2. Financial performance
8.4.3. Product portfolio
8.4.4. Recent strategic moves & developments
8.4.5. SWOT analysis

8.5. F. Hoffmann-La Roche Ltd

8.5.1. Business overview
8.5.2. Financial performance
8.5.3. Product portfolio
8.5.4. Recent strategic moves & developments
8.5.5. SWOT analysis

8.6. NIHON KOHDEN CORPORATION.

8.6.1. Business overview
8.6.2. Financial performance
8.6.3. Product portfolio
8.6.4. Recent strategic moves & developments
8.6.5. SWOT analysis

8.7. Abbott.

8.7.1. Business overview
8.7.2. Financial performance
8.7.3. Product portfolio
8.7.4. Recent strategic moves & developments
8.7.5. SWOT analysis

8.8. Sysmex Corporation 

8.8.1. Business overview
8.8.2. Financial performance
8.8.3. Product portfolio
8.8.4. Recent strategic moves & developments
8.8.5. SWOT analysis

8.9. BD.

8.9.1. Business overview
8.9.2. Financial performance
8.9.3. Product portfolio
8.9.4. Recent strategic moves & developments
8.9.5. SWOT analysis

8.10. Danaher.

8.10.1. Business overview
8.10.2. Financial performance
8.10.3. Product portfolio
8.10.4. Recent strategic moves & developments
8.10.5. SWOT analysis

Blood coagulation or clotting is a transition in the blood's physical properties leading to the incorporation of a fibrinogenic, soluble plasma protein into a stable fibrin gel. Coagulation measures are conducted mainly by a coagulometer that analyzes the capacity of the blood to clot and the time for blood clotting. The mechanism of converting blood from a liquid to a kind of gel is coagulation. Coagulation tests are carried out to treat symptoms of clotting, such as thrombosis and hemorrhage. 

The tests for coagulation check the capacity of the blood to create a clot. Although various infectious diseases including aids, HIV and lifestyle conditions like diabetes are on the rise, demand for blood testing is expected to remain strong throughout. The market for coagulating tests is on course between 2019-2026 to show strong development. Based on the strong demand for blood testing, the Coagulation Testing market  is expected to hit an estimated $3,566.0 million by 2026 end, according to ResearchDive. 

Driving factors of the market

The increasing demand for special laboratory hematology and coagulation is expected to drive the growth of the market for coagulation testing. Advanced technologies such as fluorescent microscopy, microfluidics, electrochemical sensing, and photoacoustic detection are used to build point of care (POC) instruments which are cost-effective and highly durable. POC instruments specifically calculate clotting blood electrical, electronic, and electrochemical parameters. Such technical advances are supposed to fuel the growing market for coagulation research. In turn, the increasingly growing cardiovascular issue and chronic blood disorders are projected to fuel the global market development. 

Opportunities for Coagulation Testing 

The blood-coagulation test based on smartphones is expected to drive market growth. Monitors the blood flow in patients undergoing anticoagulant therapy in this self-testing technology. The device provides patients with a facility to administer this home test. On this platform, it is possible to measure two main coagulation indexes such as prothrombin time (PT) and activated partial thromboplastin time (APTT) This application is extremely efficient and reliable. Such market trends in coagulation testing will generate huge opportunities for market growth in coagulation testing.

Limitations of Market

On the other hand, the lack of skilled expertise and increased device prices may detract from global market development. It is expected that higher costs of coagulation tools and lack of expertise would hinder the growth of the global coagulation testing industry.

Segmentation

The global market for coagulation testing has been segmented by product type into instruments and consumables. Consumable category holds the highest market share, reporting sales of $1,187.9 million in 2018, and is expected to exceed $1,847.2 million by 2026. The Instruments sector is the fastest growing business and will produce $1,718.8 million in revenue in 2026. The market for coagulation monitoring is divided into Activated Partial Thromboplastin Time (APTT), Activated Clotting Time (ACT), Prothrombin Time (PT), Thrombin Time (TT), and others, based on the study type. Coagulation testing prothrombin time market size will generate $2.475.7 million in revenue over the forecasted period. The global market for Thrombin Time would report sales of $392.3 million over the forecast period.  

Regional Outlook

According to end-users, the global market for coagulation monitoring is segmented into hospitals and clinics, research labs, home care facilities, point-of-care testing, and others. The point-of-care testing sector is the fast-growing category on the global market and it has generated $291.4 million in revenue in 2018 and is expected to generate $495.7 million in revenue by 2026. Geographically, the market is segmented into regions, viz. North America, Europe, Asia Pacific, and LAMEA. Europe's market share in coagulation research is expected to rise at a CAGR of 6.2% by producing $1.094.8 million in revenue by 2026. Market size research for Asia-Pacific coagulation would produce revenue of $848.7 million by 2026.

Key Players

Market players that check coagulation focus more on merger & acquisition and advanced product development. These are the regular approaches that the developed institutions have adopted. For starters, to focus more on market leader competition research, the study discusses the five-force model of the porter. Significant market leaders for coagulation research include: Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION., Abbott., Sysmex Corporation, BD., Danaher. Market Players tend to extend inorganic development approaches to the local markets. 
 

Purchase Options

Enquire To Buy

Personalize this research

  • Triangulate with your own data
  • Get Data as per your format and defination
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed